Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms.

Endocrine-related cancer - 1 Apr 2024

Cowzer Darren, Shah Ronak H, Chou Joanne F, Kundra Ritika, Punn Sippy, Fiedler Laura, DeMore April, Capanu Marinela, Berger Michael F, Reidy-Lagunes Diane, Raj Nitya

Abstract excerpt

In advanced pancreatic neuroendocrine neoplasms (PanNEN), there are little data detailing the frequency of genetic alterations identified in cell free DNA (cfDNA), plasma-tissue concordance of detected alterations, and clinical utility of cfDNA. Patients with metastatic PanNENs underwent cfDNA collection in routine practice. Next-generation sequencing (NGS) of cfDNA and matched tissue when available was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell-Free Nucleic Acids
Share to Genome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Neuroendocrine Tumors

Share to Pancreatic Neoplasms

Source

Identifiers

PMID: 38252063
DOI: 10.1530/ERC-23-0292

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms.PMID 38252063Read ↗

Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline ActionabilitySemantic proximity Read ↗

Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlations.Semantic proximity Read ↗

Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlationsSemantic proximity Read ↗

Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-upSemantic proximity Read ↗

Blood-based next-generation sequencing analysis of neuroendocrine neoplasmsSemantic proximity Read ↗

Cell-Free DNA, Tumor Molecular Concordance, and Clinical Correlates of Patients with Cancer Treated in a Large Community Health Care NetworkSemantic proximity Read ↗

Circulating Tumor DNA Profiling Identifies Actionable Mutations as Prognostic Markers in Advanced Neuroendocrine Tumors.Semantic proximity Read ↗

Cell-Free DNA From Metastatic Pancreatic Neuroendocrine Tumor Patients Contains Tumor-Specific Mutations and Copy Number VariationsSemantic proximity Read ↗

Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors.Semantic proximity Read ↗

Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1.Semantic proximity Read ↗

Molecular biology of pancreatic neuroendocrine tumors: From mechanism to translationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.